Related Experiment Video
Updated: May 31, 2026
05:04
Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
Published on: August 9, 2024
A perspective for clinical pharmacy curriculum development and validation in asian developing nations.
Tm Khan1, M Anwar, Kk Mueen Ahmed
1College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
Journal of Young Pharmacists : JYP
|July 7, 2011
Summary
This perspective identifies weaknesses in Asian pharmacy curriculum development, proposing a validation model. Implementing the Pharmacy Curriculum Development and Validation Model (PCDVM) can enhance education quality and healthcare in developing nations.
Area of Science:
- Pharmacy Education
- Curriculum Development
- Health Sciences
Background:
- Pharmacy education in Asian developing nations faces challenges.
- Common limitations include improper course content selection and inadequate facilities.
- Weak student evaluation systems hinder educational quality.
Purpose of the Study:
- To identify weaknesses in pharmacy curriculum development in Asian developing nations.
- To propose a methodological approach for curriculum validation.
- To introduce a model for systematic curriculum design and validation.
Main Methods:
- Reflection on personal teaching experiences.
- Identification of common limitations in existing pharmacy curricula.
- Development of the Pharmacy Curriculum Development and Validation Model (PCDVM).
Main Results:
- Improper course content selection is a significant limitation.
- Lack of facilities and flawed student evaluation are key challenges.
- A systematic approach is needed for curriculum design and validation.
Conclusions:
- The Pharmacy Curriculum Development and Validation Model (PCDVM) offers a guideline for educators.
- Implementation of the PCDVM can improve the quality of pharmacy education.
- Enhanced pharmacy education contributes to a stronger healthcare system in developing countries.
Related Concept Videos
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...